Discover the detailed record of transactions filed by 芮晨为, Cadre supérieur. Officer active across 1 company, notably 南微医学. Aggregated, 38 filings have been recorded. Regulator: SSE / SZSE (CSRC). The full history is openly available.
Declarations 38 total
● 核心技术人员 · Executives · 28 May 2026 · 新锐股份 2,000 shares @ €100.565 A股 SSE:273000000672351500 ● 核心技术人员 · Executives · 27 May 2026 · 新锐股份 1,000 shares @ €101.99 A股 SSE:273000000662435040 ● 董事 · Executives · 8 May 2026 · 引力传媒 20,000 shares A股 SSE:273000000597979940 ● 董事 · Executives · 3 Mar 2026 · 聚和材料 10,000 shares A股 SSE:273000000229705500 ● 董事 · Executives · 3 Mar 2026 · 聚和材料 13,000 shares A股 SSE:273000000229705630 ● 董事长 · Executives · 2 Mar 2026 · 聚和材料 101,600 shares A股 SSE:273000000371938050 ● 董事 · Executives · 2 Mar 2026 · 聚和材料 20,600 shares A股 SSE:273000000229705600 ● 董事 · Executives · 2 Mar 2026 · 聚和材料 8,000 shares A股 SSE:273000000229705340 ● 董事 · Executives · 2 Mar 2026 · 聚和材料 3,000 shares A股 SSE:273000000229705400 ● 董事 · Executives · 19 Jan 2026 · 聚和材料 200 shares A股 SSE:273000000229711840 ● 董事 · Executives · 23 Oct 2025 · 引力传媒 5,000 shares A股 SSE:173000009663804770 ● 监事 · Executives · 13 Dec 2023 · 聚和材料 746 shares A股 SSE:173000007168902080 Ideal exit: 8 Sept 2024 (T+270) ● 董事,高级管理人员 · Executives · 1 Dec 2023 · 南微医学 250,000 shares A股 SSE:173000007143192580 ● 董事 · Executives · 11 Apr 2023 · 成大生物 13,200 shares A股 SSE:173000006468970300 Ideal exit: 6 Jan 2024 (T+270) ● 高级管理人员 · Executives · 11 Apr 2023 · 成大生物 5,000 shares A股 SSE:173000006468970340 Ideal exit: 6 Jan 2024 (T+270) ● 董秘,董事 · Executives · 31 Mar 2023 · 神火股份 2,200 shares A股 SZSE:173000006441830900 Ideal exit: 26 Dec 2023 (T+270) ● 董事 · Executives · 29 Mar 2023 · 引力传媒 346,700 shares A股 SSE:173000006419731740 ● 董事 · Executives · 27 Mar 2023 · 引力传媒 30,800 shares A股 SSE:173000006402427900 ● 董事 · Executives · 24 Mar 2023 · 引力传媒 427,100 shares A股 SSE:173000006396974820 ● 董事,高管 · Executives · 30 Sept 2022 · 开立医疗 200,000 shares A股 SZSE:173000005934830620 ● 核心技术人员 · Executives · 23 Aug 2022 · 南微医学 2,052 shares A股 SSE:173000005804796800 Ideal exit: 20 May 2023 (T+270) ● 董事 · Executives · 28 Jul 2022 · 引力传媒 2,380,000 shares A股 SSE:173000005730496420 ● 董事 · Executives · 16 Jun 2022 · 引力传媒 150,000 shares A股 SSE:173000005605513150 ● 高级管理人员 · Executives · 22 Dec 2021 · 南微医学 8,400 shares A股 SSE:173000005457335900 Ideal exit: 18 Sept 2022 (T+270) ● 高级管理人员 · Executives · 22 Dec 2021 · 南微医学 6,750 shares A股 SSE:173000005457335970 Ideal exit: 18 Sept 2022 (T+270) 25 of 38 declarations
Load more (13 remaining) About 芮晨为 芮晨为 is a Senior Executive at 南微医学. In this role, he is responsible for managing operations and implementing the company's strategies. 南微医学 is an innovative company in the medical sector, and 芮晨为's expertise is crucial for its development.